Biotech · Private company
NiKang Therapeutics, Inc.
Track this companyFree. Adds NiKang Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- NKT2152Phase 2 · ccRCCClinicalTrials.gov · fetched Nov 12, 2026
- Oral NKT2152Phase 2 · ccRCCClinicalTrials.gov · fetched Nov 12, 2026
- palbociclibPhase 2 · ccRCCClinicalTrials.gov · fetched Nov 12, 2026
- sasanlimabPhase 2 · ccRCCClinicalTrials.gov · fetched Nov 12, 2026
- DoxorubicinPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 1 · HR+ Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- LetrozolePhase 1 · HR+ Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- NKT3447Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- NKT3964Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- NKT5097 CDK2/CDK4 dual degraderPhase 1 · HR+ Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Study With NKT5097 for Adults With Advanced/Metastatic Solid TumorsPHASE1 · RECRUITING · started Mar 25, 2025ClinicalTrials.gov NCT07029399 · fetched Nov 12, 2026
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsPHASE1 · RECRUITING · started Sep 19, 2024ClinicalTrials.gov NCT06586957 · fetched Nov 12, 2026
- A Study With NKT3447 for Adults With Advanced/Metastatic Solid TumorsPHASE1 · TERMINATED · started Feb 23, 2024ClinicalTrials.gov NCT06264921 · fetched Nov 12, 2026
- Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)PHASE2 · TERMINATED · started Jul 28, 2023ClinicalTrials.gov NCT05935748 · fetched Nov 12, 2026
- A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell CarcinomaPHASE1_PHASE2 · TERMINATED · started Oct 26, 2021ClinicalTrials.gov NCT05119335 · fetched Nov 12, 2026
- A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 1, 2020ClinicalTrials.gov NCT04524871 · fetched Nov 12, 2026